Jennifer Esposito Appointed to VivaLNK Board of Directors: Over 20 Years of Experience, Esposito Will Advise the Executive Team and Assist in Growth in the Digital Health Space

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

December 1, 2020

Jennifer Esposito joins the VivaLNK its Board of Directors.

Jennifer Esposito experience lies in the healthcare technology and medical device fields and will provide VivaLNK and its executive team a valuable resource to help direct the company’s strategic growth as it powers the world’s leading RPM (remote patient monitoring) technologies.

Esposito is an executive with over 20 years of experience in the global healthcare IT, medical device, biotechnology, and the health and life sciences industry, currently serving as the VP, Health at Magic Leap. She is currently leading Magic Leap’s Health business unit. Prior to joining Magic Leap, she held leadership roles at GE Healthcare and was more recently the General Manager of Health and Life Sciences at Intel Corporation.

In addition, Esposito has worked in academic medicine and clinical research. In her many years of experience, she has led business development, commercial and service operations, as well as both upstream and downstream strategy and marketing. Her expertise lies in driving business growth and strategies by enabling the adoption of emerging technologies in the healthcare industry.

“I believe we are on the cusp of an acceleration in the transformation of healthcare that we’ve never seen before that will improve health, quality of life, safety and security worldwide,” said Esposito. “Working alongside the incredible executive team at VivaLNK allows my passion for healthcare technology to be fully leveraged. I am honored to have a part in the strategy and continued growth of this innovative company.”

The VivaLNK platform has enabled over 90 healthcare solution partners in 22 countries worldwide, and includes applications for remote and clinical patient monitoring for mobile cardiac telemetry, pharmaceutical clinical trials, and COVID patient monitoring to name a few.

“In order for remote monitoring and telemedicine to reach its full potential, solution providers and clinical or research entities need to be able to depend on the capture and transmission of data, as well as seamlessly implement RPM into existing and new infrastructure. Jennifer not only has deep understanding of this space, but also knows the challenges of our partners well, and I’m thrilled to have her assistance in delivering the highest-quality, turnkey service on the market that ultimately changes the status and adoption of RPM today,” said Jiang Li, CEO of VivaLNK.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.